Compare Novavax Inc (NVAX) vs Ferrari NV (RACE) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Novavax Inc vs Ferrari NV — how do they compare? Novavax Inc trades at $8.08 (market cap $1.30B), while Ferrari NV trades at $367.23 (market cap $65.48B). The key difference: Ferrari NV is far larger — about 50.4× Novavax Inc's market cap, and Ferrari NV pays a 1.14% dividend while Novavax Inc pays none. Which is the better fit depends on your goals.
| NVAX | RACE | |
|---|---|---|
Market Cap | $1.30B | $65.48B |
Sector | Health | Consumer Cyclical |
52-Week High | $11.19 | $517.65 |
52-Week Low | $6.22 | $314.63 |
Enterprise Value | $800.50M | $66.69B |
Dividend Yield | — | 1.14% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Novavax Inc
Novavax, Inc. is a clinical stage biotechnology company. The Company creates novel vaccines to address a broad range of infectious diseases worldwide using proprietary virus-like particle (VLP) technology.
Read more on NVAX →About Ferrari NV
Ferrari engineers and manufactures some of the world's most expensive exotic sports cars. The Ferrari brand is synonymous with Formula One racing, exclusivity, Italian design, and state-of-the-art technology. Ferrari also has a captive finance company that provides funding for dealers and clients.
Read more on RACE →
